Use of Janus kinase inhibitors in COVID-19: a prospective observational series in 522 individuals

por Melikhov, Oleg, Kruglova, Tatiana, Lytkina, Karine, Melkonyan, Georgy, Prokhorovich, Elena, Putsman, Gleb, Rodoman, Grigory, Vertkin, Arkady, Zagrebneva, Alena, Stebbing, Justin
Publicado 2021

Tocilizumab, netakimab, and baricitinib in patients with mild-to-moderate COVID-19: An observational study

por Bryushkova, Ekaterina A., Skatova, Valeria D., Mutovina, Zinaida Y., Zagrebneva, Alena I., Fomina, Daria S., Kruglova, Tatyana S., Akopyan, Anna A., Strazhesko, Irina D., Lukyanov, Sergey A., Tkacheva, Olga N., Lysenko, Maryana A., Chudakov, Dmitry M.
Publicado 2022